Medpace Inc.

323.09
-3.25 (-1.00%)
At close: Mar 18, 2025, 3:59 PM
323.74
0.20%
After-hours: Mar 18, 2025, 07:55 PM EDT
-1.00%
Bid 292.13
Market Cap 9.84B
Revenue (ttm) 2.08B
Net Income (ttm) 398.09M
EPS (ttm) 12.64
PE Ratio (ttm) 25.56
Forward PE 26.72
Analyst Hold
Ask 355.35
Volume 311,999
Avg. Volume (20D) 309,024
Open 325.85
Previous Close 326.34
Day's Range 322.08 - 325.80
52-Week Range 302.01 - 459.77
Beta 1.47

About MEDP

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory...

Sector Healthcare
IPO Date Aug 11, 2016
Employees 5,900
Stock Exchange NASDAQ
Ticker Symbol MEDP
Full Company Profile

Analyst Forecast

According to 9 analyst ratings, the average rating for MEDP stock is "Hold." The 12-month stock price forecast is $367, which is an increase of 13.59% from the latest price.

Stock Forecasts

Next Earnings Release

Medpace Inc. is scheduled to release its earnings on Apr 21, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-7.52%
Medpace Holdings shares are trading lower. The com... Unlock content with Pro Subscription
1 month ago
+0.12%
Medpace Holdings shares are trading lower. The company reported Q4 financial results.